Home › Funds › PFM Health Sciences, LP › SYK

PFM Health Sciences, LP position in SYK

STRYKER CORPORATION · Health Care

PFM Health Sciences, LP reported holding 56,637 shares of SYK (STRYKER CORPORATION) in its Q2 2026 13F filing — a position valued at US$17.8M, representing 1.56% of its reported portfolio and ranking #17 among its reported holdings. PFM Health Sciences, LP has disclosed SYK holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)56.64K sh
Reported value held$17.83M
Portfolio Weight1.56%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's SYK position evolved

PFM Health Sciences, LP first disclosed a stake in SYK in Q3 2023 at 12,106 shares (US$3.3M). The position peaked in Q2 2024 at 114,297 shares, worth US$38.9M. Across 9 filings, PFM Health Sciences, LP increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 56,637 shares valued at US$17.8M — an increase of 34,680 shares quarter over quarter.. Notable position changes include a 384% increase in Q4 2023 (shares rose 20% over the following quarter), a 107% increase in Q2 2024 (shares rose 6% over the following quarter), a 158% increase in Q2 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.11K $3.31M New
Q4 2023 58.63K $17.56M Add
Q1 2024 55.09K $19.72M Reduce
Q2 2024 114.30K $38.89M Add
Q3 2024 67.01K $24.21M Reduce
Q4 2024 32.35K $11.65M Reduce
Q4 2025 50.85K $17.87M New
Q1 2026 21.96K $7.21M Reduce
Q2 2026 56.64K $17.83M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SYK and 13F data

SYK (STRYKER CORPORATION) is a Health Care company. 25 other funds we track also report a position in SYK — the largest reported positions include JPMorgan Chase & Co (US$5.71B), GREENLEAF TRUST (US$4.79B), PRICE T ROWE ASSOCIATES INC /MD/ (US$3.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SYK

All SYK fund holders →

FAQ

How long has PFM Health Sciences, LP held SYK?

PFM Health Sciences, LP has disclosed SYK holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

What is PFM Health Sciences, LP's current position in SYK?

As of Q2 2026, PFM Health Sciences, LP holds 56.64K shares of SYK (STRYKER CORPORATION), valued at $17.83M, representing 1.56% of its reported portfolio and ranking #17.

Has PFM Health Sciences, LP been buying or selling SYK?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP increased its position in SYK. The position peaked in Q2 2024 at 114.30K shares.

Which other funds hold SYK?

Other major institutional holders of SYK include JPMorgan Chase & Co, GREENLEAF TRUST, PRICE T ROWE ASSOCIATES INC /MD/, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.